Search research articles
Contact Us
Filters
Showing results (271-280 of 284) with videos related to
Page
of 29
Sort By:
Research Square
|
May 25, 2026
A high-penetrance intergenic variant at 9p21 confers melanoma susceptibility
Maria Teresa Landi, Linh Bui-Raborn, Lorenza Pastorino, et al.
Clinical and Experimental Dermatology
|
April 15, 2025
BRodalumab effectiveness in psoriatic patients that experienced anti-IL17 Intra-Class failure: a multicentre, retrospective study (BRIC - Study) IL-PSO (Italian Landscape Psoriasis)
Diego Orsini, Dario Graceffa, Martina Burlando, et al.
Clinical and Experimental Dermatology
|
June 27, 2025
Clinical Course of Atopic Dermatitis after Dupilumab Discontinuation: A Multicenter Real-World Study
Francesca Barei, Stefano Macchi, Paolo Calzari, et al.
The Lancet. Child & Adolescent Health
|
March 16, 2019
MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort
Cristina Pellegrini, Francesca Botta, Daniela Massi, et al.
Pharmaceuticals (Basel, Switzerland)
|
October 26, 2024
Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study
Elena Campione, Fabio Artosi, Ruslana Gaeta Shumak, et al.
Genome Medicine
|
December 26, 2018
Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls
Jung Kim, Wen Luo, Mingyi Wang, et al.
Dermatology Practical & Conceptual
|
November 14, 2025
Brodalumab Efficacy in Psoriasis Patients with Inadequate Response to IL-23 or IL-12/23 Inhibitors: Multicenter Italian Retrospective Analysis - IL PSO (Italian Landscape Psoriasis)
Diego Orsini, Maria Concetta Fargnoli, Martina Burlando, et al.
Clinical and Experimental Dermatology
|
April 15, 2026
Dupilumab for Prurigo Nodularis: Real-World Outcomes Up to 104 Weeks from the DUPItaPN Study
Marina Talamonti, Edoardo Mortato, Alessandra Narcisi, et al.
Italian Journal of Dermatology and Venereology
|
May 29, 2024
Italian National Registry of Alopecia Areata: an epidemiological study of 699 Italian patients
Bianca Maria Piraccini, Luca Rapparini, Federico Quadrelli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 23, 2025
Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results
Bianca Maria Piraccini, Stephano Cedirian, Francesca Pampaloni, et al.
Page
of 29
Search research articles
Search
Showing results (271-280 of 284) with videos related to
Sort By:
Page
of 29
Research Square
|
May 25, 2026
A high-penetrance intergenic variant at 9p21 confers melanoma susceptibility
Maria Teresa Landi, Linh Bui-Raborn, Lorenza Pastorino, et al.
Clinical and Experimental Dermatology
|
April 15, 2025
BRodalumab effectiveness in psoriatic patients that experienced anti-IL17 Intra-Class failure: a multicentre, retrospective study (BRIC - Study) IL-PSO (Italian Landscape Psoriasis)
Diego Orsini, Dario Graceffa, Martina Burlando, et al.
Clinical and Experimental Dermatology
|
June 27, 2025
Clinical Course of Atopic Dermatitis after Dupilumab Discontinuation: A Multicenter Real-World Study
Francesca Barei, Stefano Macchi, Paolo Calzari, et al.
The Lancet. Child & Adolescent Health
|
March 16, 2019
MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort
Cristina Pellegrini, Francesca Botta, Daniela Massi, et al.
Pharmaceuticals (Basel, Switzerland)
|
October 26, 2024
Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study
Elena Campione, Fabio Artosi, Ruslana Gaeta Shumak, et al.
Genome Medicine
|
December 26, 2018
Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls
Jung Kim, Wen Luo, Mingyi Wang, et al.
Dermatology Practical & Conceptual
|
November 14, 2025
Brodalumab Efficacy in Psoriasis Patients with Inadequate Response to IL-23 or IL-12/23 Inhibitors: Multicenter Italian Retrospective Analysis - IL PSO (Italian Landscape Psoriasis)
Diego Orsini, Maria Concetta Fargnoli, Martina Burlando, et al.
Clinical and Experimental Dermatology
|
April 15, 2026
Dupilumab for Prurigo Nodularis: Real-World Outcomes Up to 104 Weeks from the DUPItaPN Study
Marina Talamonti, Edoardo Mortato, Alessandra Narcisi, et al.
Italian Journal of Dermatology and Venereology
|
May 29, 2024
Italian National Registry of Alopecia Areata: an epidemiological study of 699 Italian patients
Bianca Maria Piraccini, Luca Rapparini, Federico Quadrelli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 23, 2025
Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results
Bianca Maria Piraccini, Stephano Cedirian, Francesca Pampaloni, et al.
Page
of 29